Publications

Journal Publications 2013

Analysis of microbiota alterations in inflammasome-deficient mice.
Author(s):
Elinav E, Thaiss CA, Flavell RA.
Source: Methods in Molecular Biology 2013 ;
Read
Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer.
Author(s):
Hu B, Elinav E (first co-author), Huber S, Strowig T, Hao LM, Hafemann A, Jin CC, Eisenbarth SC, Flavell RA.
Source: PNAS 2013 ;
Read
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms.
Author(s):
Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA.
Source: Nature Reviews Cancer 2013 ;
Read
The microbiota: A new player in the etiology of colorectal cancer.
Author(s):
Levy M, Thaiss CA, Elinav E.
Source: Current Colorectal Cancer Reports 2013 ;
Read
The intestinal microbiota in chronic liver disease.
Author(s):
Henao-Mejia J, Elinav E, Thaiss CA, Flavell RA.
Source: Advances in Immunology 2013 ;
Read
Role of the intestinal microbiome in liver disease.
Author(s):
Henao-Mejia J, Elinav E, Thaiss CA, Licona-Limon P, Flavell RA.
Source: Journal of Autoimmunity 2013 ;
Read
Novel superactive leptin antagonists and their potential therapeutic applications.
Author(s):
Gertler A, Elinav E.
Source: Current Pharmacological Design 2013 ;
Read
The intestinal microbiota in chronic liver disease.
Author(s):
Henao-Mejia J, Elinav E (first co-author), Thaiss CA, Flavell RA.
Source: Advances in Immunology 2013 ;
Read
IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic.
Author(s):
Zenewicz LA, Yin X, Wang G, Elinav E, Hao L, Zhao L, Flavell RA.
Source: Journal of Immunology 2013 ;
Read
Harnessing nanomedicine for mucosal theranostics-A silver bullet at last?.
Author(s):
Elinav E, Peer D.
Source: ACS Nano 2013 ;
Read
Integrative inflammasome activity in the regulation of intestinal mucosal immune responses.
Author(s):
Elinav E, Henao-Mejia J, Flavell RA.
Source: Mucosal Immunology 2013 ;
Read
©2013. All rights reserved